| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Antigenic Specificity | Human Factor V (F.V) |
|---|
| Clone | polyclonal |
|---|
| Host Species | Sheep |
|---|
| Reactive Species | human |
|---|
| Isotype | n/a |
|---|
| Format | unconjugated |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | IEP, ELISA |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | Sheep Anti-Human Factor V (F.V) polyclonal antibody for IEP, ELISA. Factor V (formerly referred to as accelerator globulin and labile factor) is a large glycoprotein (320 kDa) that is produced in the liver. The gene that encodes factor V (F.V) is located on chromosome 1. A congenital deficiency of F.V is a hemorrhagic disorder inherited as an autosomal recessive disease. The concentration of F.V in plasma is typically 10 μg/ml. F.V is a pro-cofactor that is activated through limited proteolysis by thrombin, or by activated factor X in the presence of phospholipid surface. Other physiologic activators of F.V include plasmin, neutrophil elastase and platelet calpain. The activated cofactor (F.Va) is an essential component of the prothrombin activator complex, which consists of F.Va, activated factor X, calcium and anionic phospholipid surface. The intact prothrombinase complex activates prothrombin to thrombin at a rate 300,000-fold greater than activated factor X alone. In a positive feedback loop, the thrombin generated accelerates its own generation by activating more F.V to F.Va. Thrombin also acts to down-regulate F.Va indirectly by activating Protein C, which inactivates F.Va cofactor activity. |
|---|
| Immunogen | Human factor V purified from plasma. |
|---|
| Other Names | n/a |
|---|
| Gene, Accession # | Gene ID: 2153, UniProt: P12259 |
|---|
| Catalog # | CABT-L414 |
|---|
| Price | |
|---|
| Order / More Info | Human Factor V (F.V) Antibody from CREATIVE DIAGNOSTICS |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|